Digipharm
| Digipharm | |
|---|---|
 Digipharm ICO Review | |
| Digipharm ICO | |
| Ticker: | DPH |
| ICO start: | 0000-00-00 00:00:00 |
| ICO end: | 0000-00-00 00:00:00 |
| Price: | 1 DPH = 1 USD |
| Bonus: | 1 |
| Tokens: | 65 DPH |
| Tokentype: | ERC20 |
| Platform: | Ethereum |
| Distributed: | 65% |
| Accepting: | ETH |
Digipharm bypasses infrastructural limitations to enable the implementation of flexible value-based pricing agreements using smart contracts, the development of unprecedented evidence platforms and the ability to reward patients for contributing their data. They aim to utilize innovative blockchain technology to overcome barriers to patient access and innovative pricing, reduce costs for all stakeholders, and bypass infrastructural limitations to drive value improvement, incentivize innovation and expedite the transformation to personalized healthcare.
Their solutions aim to accelerate the much needed restructuring of healthcare delivery systems to a value-based approach.
Contents
Description
Digipharms’ solutions aim to accelerate the much needed restructuring of healthcare delivery systems to a value-based approach. The inherent flaws of current global healthcare infrastructure result in substantial inefficiency, wastage and sub-optimal health outcomes for the most important stakeholder; the patient. In healthcare today, there is a lack of incentive for health systems and providers to focus on mutually beneficial collaboration and the maximisation of patient outcomes.
Digipharm aims to utilise innovative blockchain technology to overcome barriers to patient access and innovative pricing, reduce costs for all stakeholders, and bypass infrastructural limitations to drive value improvement, incentivise innovation and expedite the transformation to personalised healthcare.
Team
| name: | title: | links: | group: | photo: | iss: |
|---|---|---|---|---|---|
| Ahmed Abdulla | Founder/CEO | https://www.linkedin.com/in/aahealtheconomics |  | 3.1 | |
| Girisha Fernando | Co-Founder/COO | https://www.linkedin.com/in/girisha-fernando-08b55537 |  | 3.1 | |
| Zach Daniels | CTO | https://www.linkedin.com/in/zach-d-1b326147 |  | 3.1 | |
| Ralf Gerteis | Commercial Strategy | https://www.linkedin.com/in/ralf-gerteis-1765aa24 |  | 12.6 | |
| Alexander Sverdlov | Cybersecurity Strategy | https://www.linkedin.com/in/asverdlov |  | 3.1 | |
| Meredith Darden | Digital Marketing Lead | https://www.linkedin.com/in/meredithadarden/ |  | 7.2 | |
| Alexey Popov | Web Development | [email protected] |  | 8.6 | |
| Michael Gubert | UI/UX Design | [email protected] |  | 3.1 | |
| Leon Rebolledo | Lead Architect | https://www.linkedin.com/in/leon-rebolledo-7a6383a6 |  | 3.1 | |
| Rolf Günter | Legal Counsel | https://www.linkedin.com/in/rolfguenter |  | 3.1 | |
| Bobby Kaura | Business Development | https://www.linkedin.com/in/bobbykaura |  | 3.1 | |
| Mohamed Abdulla | Clinical Transformation | https://www.linkedin.com/in/dr-mohamed-abdulla-919579155 |  | 3.1 | |
| Hasham Al-Meshhedani | Patient Engagement | https://www.linkedin.com/in/hasham-al-meshhedani-955363151 |  | 3.1 | |
| Ali Al-Sudani | Clinical Pharmacist | https://www.linkedin.com/in/ali-al-sudani-16ba54149 |  | 3.1 | |
| Rami Radwan | Clinical Relations | https://www.linkedin.com/in/rami-radwan-46786ab9 |  | 3.1 | |
| Peter Sandbach | Communications Director | https://www.linkedin.com/in/petersandbach |  | 3.1 | |
| Debra De Silva-Sun | HEOR & Pricing Analyst | https://www.linkedin.com/in/debra-de-silva-sun-657ba669 |  | 3.1 | |
| Marko Granic | Graphic Designer | https://www.linkedin.com/in/marko-granic-543946157 |  | 3.1 | |
| Sven Möller | ICO Advisor Swisscom Blockchain AG | https://www.linkedin.com/in/sven-moeller-1ab32328 | Advisors |  | 3.8 |
| Kamal Youssefi | Enterprise Blockchain Advisor Swisscom Blockchain AG | https://www.linkedin.com/in/kamal-youssefi-20180077 | Advisors |  | 3.1 |
| Waldemar Scherer | Life Sciences Blockchain Advisor Swisscom Blockchain AG | Advisors |  | 3.1 | |
| Sam Mantle | Health & Life Sciences Technology Advisor Luxoft | https://www.linkedin.com/in/sam-mantle-24833235 | Advisors |  | 3.1 |
| Daniel Heller | PR Advisor Partner, Farner Consulting AG | https://www.linkedin.com/in/daniel-heller-00492719/ | Advisors |  | 14.9 |
| Claudio Staub | Co-Head Startup Communications Farner Consulting AG | https://www.linkedin.com/in/claudiostaub/ | Advisors |  | 3.1 |
| Anas Aman | Quality and Testing IBM | https://www.linkedin.com/in/anas-aman/ | Advisors |  | 3.1 |
| Lloyd Jefferies | CRM Advisor KPMG | https://www.linkedin.com/in/lloydjefferies | Advisors |  | 3.1 |
| Per-Olof Thuresson | Health Economist Roche | https://www.linkedin.com/in/per-olof-thuresson-0720835 | Advisors |  | 3.1 |
| Fadi Chehadah | Health Economist NICE UK | https://www.linkedin.com/in/fadi-chehadah-ab751583 | Advisors |  | 3.1 |
External links
Digipharm on Twitter
Digipharm on Telegram
Digipharm on Facebook
Digipharm on Medium
Digipharm on Reddit
Digipharm on Youtube
Digipharm Official Website
Digipharm Bounty
Digipharm Whitepaper
Twitter
Telegram
